走在十字路口:癌症存活率中的心脏代谢风险 - 一个全面的审查
Arif Albulushi1,2, Aisha Al Balushi3, Muhhamed Shahzad4
1Department of Adult Cardiology, National Heart Center, The Royal Hospital, Muscat, Oman. dr.albulushi@gmail.com.
Cardio-oncology (London, England)
|August 13, 2024
概括
癌症幸存者经常面临心脏代谢风险,如高血压和糖尿病,由于癌症病史和治疗. 管理这些风险,包括肥胖,对于长期健康和预防心血管疾病至关重要.
科学领域:
- 在瘤学瘤学.
- 心脏病学 心脏病学
- 代谢健康 代谢健康
背景情况:
- 癌症幸存者数量正在增加,幸存者越来越多地经历心脏代谢风险.
- 这些风险源于癌症病史和治疗方法,包括高血压,失脂症,糖尿病,肥胖和代谢综合征.
研究的目的:
- 综合当前关于癌症幸存者的心脏代谢风险的研究.
- 探索人口统计,癌症类型和治疗对幸存者的心脏代谢健康的影响.
- 倡导综合管理策略,并讨论结果的影响.
主要方法:
- 对癌症幸存者的心脏代谢健康现有研究的系统审查和综合.
- 对人口统计学,癌症特异性和与治疗有关的因素的分析.
- 检查心脏代谢风险对心血管结果和存活率的影响.
主要成果:
- 在癌症幸存者中,传统心脏代谢风险因素 (高血压,脂质失调,糖尿病) 和新兴问题 (肥胖,代谢综合征) 的高患病率.
- 人口变量,癌症类型和治疗方式显著影响幸存者的心脏代谢健康.
- 心脏代谢风险与心血管疾病的发展增加,未来的事件以及整体存活率降低有关.
结论:
- 综合性,多学科的方法对于管理癌症幸存者的心脏代谢健康至关重要.
- 生活方式干预,如运动和风险因素控制,可以改善结果.
- 需要进一步的研究,以优化癌症幸存者面临心脏代谢挑战的长期福祉.
相关概念视频
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Psychoneuroimmunology: Diabetes and Cancer
27
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
27
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


